Interrelationship between Epstein–Barr virus infection in gastric carcinomas and the expression of apoptosis‐associated proteins
Authors:
- 1 February 2001
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 38 (2) , 111-119
Abstract
Aims: Epstein–Barr virus (EBV) and its associated proteins may be protective against the occurrence of apoptosis that would normally inhibit cancer development and progression. Alternatively, the viral infection may cause altered or mutated expression of oncogenes or tumour suppressor genes that are necessary for tumour development, an action that may also involve apoptosis. In this study, a relationship was sought between occurrence of EBV infection, expression of apoptosis‐associated proteins (tumour suppressor gene p53 and oncogenes c‐myc and bcl‐2) and levels of cell death (apoptosis or necrosis) in 119 cases of gastric carcinoma.Methods and results: The EBV status of the gastric carcinomas (using the EBV‐encoded small RNA I (EBER‐1) and in‐situ hybridization), stage and grade of tumour and sex of patients were compared for bcl‐2, p53 and c‐myc expression patterns. EBER‐1 was detected in approximately 20% of cases studied. There was no significant correlation between levels of cell death in the tumour tissue and EBV status. In the protein analyses, development and progression of gastric carcinoma, with or without EBV infection, was independent of bcl‐2 expression. However, in gastric cancers with EBV infection, p53 overexpression was inhibited and c‐myc expression was increased in early stage cancers, in comparison with decreased c‐myc expression in late stage cancers.Conclusions: The p53 and c‐myc expression patterns indicate that EBV‐infected gastric carcinomas are less likely to have a natural regression via apoptosis at an early stage and explain, in part, the resistance to treatment of late stage of gastric cancers.Keywords
This publication has 32 references indexed in Scilit:
- The Myc oncoprotein: a critical evaluation of transactivation and target gene regulationOncogene, 1999
- Apoptosis in colorectal carcinoma occurring in patients aged 45 years and under: relationship to prognosis, mitosis, and immunohistochemical demonstration of p53, c-myc and bcl-2 protein productsThe Journal of Pathology, 1997
- Infrequent Overexpression of p53 Protein in Epstein‐Barr Virus‐associated Gastric CarcinomasJapanese Journal of Cancer Research, 1997
- Burkitt's lymphoma cells are resistant to programmed cell death in the presence of the epstein‐barr virus latent antigen EBNA‐4International Journal of Cancer, 1995
- Epstein-Barr virus and gastric remnant cancerCancer, 1994
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.Journal of Cell Biology, 1992
- p53, guardian of the genomeNature, 1992
- Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell deathCell, 1991
- Activation of Epstein–Barr virus latent genes protects human B cells from death by apoptosisNature, 1991
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990